209 related articles for article (PubMed ID: 29740816)
1. The Impact of the Hospital Readmissions Reduction Program across Insurance Types in California.
Zingmond DS; Liang LJ; Parikh P; Escarce JJ
Health Serv Res; 2018 Dec; 53(6):4403-4415. PubMed ID: 29740816
[TBL] [Abstract][Full Text] [Related]
2. Association Between Hospital Penalty Status Under the Hospital Readmission Reduction Program and Readmission Rates for Target and Nontarget Conditions.
Desai NR; Ross JS; Kwon JY; Herrin J; Dharmarajan K; Bernheim SM; Krumholz HM; Horwitz LI
JAMA; 2016 Dec; 316(24):2647-2656. PubMed ID: 28027367
[TBL] [Abstract][Full Text] [Related]
3. Association of the Hospital Readmissions Reduction Program With Mortality During and After Hospitalization for Acute Myocardial Infarction, Heart Failure, and Pneumonia.
Khera R; Dharmarajan K; Wang Y; Lin Z; Bernheim SM; Wang Y; Normand ST; Krumholz HM
JAMA Netw Open; 2018 Sep; 1(5):e182777. PubMed ID: 30646181
[TBL] [Abstract][Full Text] [Related]
4. Association Between Financial Incentives in Medicare's Hospital Readmissions Reduction Program and Hospital Readmission Performance.
Hoffman GJ; Yakusheva O
JAMA Netw Open; 2020 Apr; 3(4):e202044. PubMed ID: 32242906
[TBL] [Abstract][Full Text] [Related]
5. Further Evidence on the System-Wide Effects of the Hospital Readmissions Reduction Program.
Demiralp B; He F; Koenig L
Health Serv Res; 2018 Jun; 53(3):1478-1497. PubMed ID: 28480598
[TBL] [Abstract][Full Text] [Related]
6. Impact of the Medicare hospital readmissions reduction program on vulnerable populations.
Gai Y; Pachamanova D
BMC Health Serv Res; 2019 Nov; 19(1):837. PubMed ID: 31727168
[TBL] [Abstract][Full Text] [Related]
7. Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia.
Wadhera RK; Joynt Maddox KE; Wasfy JH; Haneuse S; Shen C; Yeh RW
JAMA; 2018 Dec; 320(24):2542-2552. PubMed ID: 30575880
[TBL] [Abstract][Full Text] [Related]
8. Hospital revisits within 30 days after discharge for medical conditions targeted by the Hospital Readmissions Reduction Program in the United States: national retrospective analysis.
Wadhera RK; Joynt Maddox KE; Kazi DS; Shen C; Yeh RW
BMJ; 2019 Aug; 366():l4563. PubMed ID: 31405902
[TBL] [Abstract][Full Text] [Related]
9. Cirrhosis as a Comorbidity in Conditions Subject to the Hospital Readmissions Reduction Program.
Rosenblatt R; Cohen-Mekelburg S; Shen N; Tafesh Z; Lucero C; Kumar S; Fortune B; Liu SY; Brown R; Jesudian A
Am J Gastroenterol; 2019 Sep; 114(9):1488-1495. PubMed ID: 31180921
[TBL] [Abstract][Full Text] [Related]
10. Misclassification of Hospital Performance Under the Hospital Readmissions Reduction Program: Implications for Value-Based Programs.
Shen C; Wadhera RK; Yeh RW
JAMA Cardiol; 2021 Mar; 6(3):332-335. PubMed ID: 33052371
[TBL] [Abstract][Full Text] [Related]
11. Readmissions and costs among younger and older adults for targeted conditions during the enactment of the hospital readmission reduction program.
Lu CH; Clark CM; Tober R; Allen M; Gibson W; Bednarczyk EM; Daly CJ; Jacobs DM
BMC Health Serv Res; 2021 Apr; 21(1):386. PubMed ID: 33902569
[TBL] [Abstract][Full Text] [Related]
12. Patient Readmission Rates For All Insurance Types After Implementation Of The Hospital Readmissions Reduction Program.
Ferro EG; Secemsky EA; Wadhera RK; Choi E; Strom JB; Wasfy JH; Wang Y; Shen C; Yeh RW
Health Aff (Millwood); 2019 Apr; 38(4):585-593. PubMed ID: 30933582
[TBL] [Abstract][Full Text] [Related]
13. Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure.
Gupta A; Allen LA; Bhatt DL; Cox M; DeVore AD; Heidenreich PA; Hernandez AF; Peterson ED; Matsouaka RA; Yancy CW; Fonarow GC
JAMA Cardiol; 2018 Jan; 3(1):44-53. PubMed ID: 29128869
[TBL] [Abstract][Full Text] [Related]
14. Relative Effects of the Hospital Readmissions Reduction Program on Hospitals That Serve Poorer Patients.
Wasfy JH; Bhambhani V; Healy EW; Choirat C; Dominici F; Wadhera RK; Shen C; Wang Y; Yeh RW
Med Care; 2019 Dec; 57(12):968-976. PubMed ID: 31567860
[TBL] [Abstract][Full Text] [Related]
15. Readmissions Reduction Program: Mortality and Readmissions for Chronic Obstructive Pulmonary Disease.
Puebla Neira DA; Hsu ES; Kuo YF; Ottenbacher KJ; Sharma G
Am J Respir Crit Care Med; 2021 Feb; 203(4):437-446. PubMed ID: 32871097
[No Abstract] [Full Text] [Related]
16. Hospital Readmissions Reduction Program: Intended and Unintended Effects.
Chen M; Grabowski DC
Med Care Res Rev; 2019 Oct; 76(5):643-660. PubMed ID: 29199504
[TBL] [Abstract][Full Text] [Related]
17. Readmission Rates for Chronic Obstructive Pulmonary Disease Under the Hospital Readmissions Reduction Program: an Interrupted Time Series Analysis.
Buhr RG; Jackson NJ; Kominski GF; Dubinett SM; Mangione CM; Ong MK
J Gen Intern Med; 2020 Dec; 35(12):3581-3590. PubMed ID: 32556878
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Hospital Readmissions From the Emergency Department After Implementation of Medicare's Hospital Readmissions Reduction Program.
Hsuan C; Carr BG; Hsia RY; Hoffman GJ
JAMA Netw Open; 2020 May; 3(5):e203857. PubMed ID: 32356883
[TBL] [Abstract][Full Text] [Related]
19. Medicare's Hospital Readmission Reduction Program reduced fall-related health care use: An unexpected benefit?
Hoffman GJ; Alexander NB; Ha J; Nguyen T; Min LC
Health Serv Res; 2024 Feb; 59(1):e14246. PubMed ID: 37806664
[TBL] [Abstract][Full Text] [Related]
20. Trends in 30- and 90-Day Readmission Rates for Heart Failure.
Khan MS; Sreenivasan J; Lateef N; Abougergi MS; Greene SJ; Ahmad T; Anker SD; Fonarow GC; Butler J
Circ Heart Fail; 2021 Apr; 14(4):e008335. PubMed ID: 33866827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
